C129H154F7N19O11 — CID 161365193
5-fluoro-3-[[4-[(2-fluorophenoxy)methyl]piperidin-1-yl]methyl]-2-methoxypyrazine;1-[1-[(6-fluoro-3-methoxypyrazin-2-yl)methyl]piperidin-4-yl]-2-(2-fluorophenyl)ethanone;2-(2-fluorophenyl)-1-[1-[(3-methoxypyrazin-2-yl)methyl]piperidin-4-yl]ethanone;2-(4-fluorophenyl)-1-[1-[[3-[(2-methylpropan-2-yl)oxy]pyrazin-2-yl]methyl]piperidin-4-yl]ethanone;3-(2-fluorophenyl)-2-[1-[[3-[(2-methylpropan-2-yl)oxy]pyrazin-2-yl]methyl]piperidin-4-yl]propanenitrile;1-[1-[[3-[(2-methylpropan-2-yl)oxy]pyrazin-2-yl]methyl]piperidin-4-yl]-2-(2-phenylphenyl)ethanone (PubChem CID 161365193) has the molecular formula C129H154F7N19O11 and a molecular weight of 2279.76 g/mol. Its IUPAC name is 5-fluoro-3-[[4-[(2-fluorophenoxy)methyl]piperidin-1-yl]methyl]-2-methoxypyrazine;1-[1-[(6-fluoro-3-methoxypyrazin-2-yl)methyl]piperidin-4-yl]-2-(2-fluorophenyl)ethanone;2-(2-fluorophenyl)-1-[1-[(3-methoxypyrazin-2-yl)methyl]piperidin-4-yl]ethanone;2-(4-fluorophenyl)-1-[1-[[3-[(2-methylpropan-2-yl)oxy]pyrazin-2-yl]methyl]piperidin-4-yl]ethanone;3-(2-fluorophenyl)-2-[1-[[3-[(2-methylpropan-2-yl)oxy]pyrazin-2-yl]methyl]piperidin-4-yl]propanenitrile;1-[1-[[3-[(2-methylpropan-2-yl)oxy]pyrazin-2-yl]methyl]piperidin-4-yl]-2-(2-phenylphenyl)ethanone.
| Compound Name | 5-fluoro-3-[[4-[(2-fluorophenoxy)methyl]piperidin-1-yl]methyl]-2-methoxypyrazine;1-[1-[(6-fluoro-3-methoxypyrazin-2-yl)methyl]piperidin-4-yl]-2-(2-fluorophenyl)ethanone;2-(2-fluorophenyl)-1-[1-[(3-methoxypyrazin-2-yl)methyl]piperidin-4-yl]ethanone;2-(4-fluorophenyl)-1-[1-[[3-[(2-methylpropan-2-yl)oxy]pyrazin-2-yl]methyl]piperidin-4-yl]ethanone;3-(2-fluorophenyl)-2-[1-[[3-[(2-methylpropan-2-yl)oxy]pyrazin-2-yl]methyl]piperidin-4-yl]propanenitrile;1-[1-[[3-[(2-methylpropan-2-yl)oxy]pyrazin-2-yl]methyl]piperidin-4-yl]-2-(2-phenylphenyl)ethanone |
|---|---|
| PubChem CID | 161365193 |
| Molecular Formula | C129H154F7N19O11 |
| Molecular Weight | 2279.76 g/mol |
| Exact Mass | 2278.20 |
| IUPAC Name | 5-fluoro-3-[[4-[(2-fluorophenoxy)methyl]piperidin-1-yl]methyl]-2-methoxypyrazine;1-[1-[(6-fluoro-3-methoxypyrazin-2-yl)methyl]piperidin-4-yl]-2-(2-fluorophenyl)ethanone;2-(2-fluorophenyl)-1-[1-[(3-methoxypyrazin-2-yl)methyl]piperidin-4-yl]ethanone;2-(4-fluorophenyl)-1-[1-[[3-[(2-methylpropan-2-yl)oxy]pyrazin-2-yl]methyl]piperidin-4-yl]ethanone;3-(2-fluorophenyl)-2-[1-[[3-[(2-methylpropan-2-yl)oxy]pyrazin-2-yl]methyl]piperidin-4-yl]propanenitrile;1-[1-[[3-[(2-methylpropan-2-yl)oxy]pyrazin-2-yl]methyl]piperidin-4-yl]-2-(2-phenylphenyl)ethanone |
| SMILES | CC(C)(C)Oc1nccnc1CN1CCC(C(=O)Cc2ccc(F)cc2)CC1.CC(C)(C)Oc1nccnc1CN1CCC(C(=O)Cc2ccccc2-c2ccccc2)CC1.CC(C)(C)Oc1nccnc1CN1CCC(C(C#N)Cc2ccccc2F)CC1.COc1ncc(F)nc1CN1CCC(C(=O)Cc2ccccc2F)CC1.COc1ncc(F)nc1CN1CCC(COc2ccccc2F)CC1.COc1nccnc1CN1CCC(C(=O)Cc2ccccc2F)CC1 |
| InChI | InChI=1S/C28H33N3O2.C23H29FN4O.C22H28FN3O2.C19H21F2N3O2.C19H22FN3O2.C18H21F2N3O2/c1-28(2,3)33-27-25(29-15-16-30-27)20-31-17-13-22(14-18-31)26(32)19-23-11-7-8-12-24(23)21-9-5-4-6-10-21;1-23(2,3)29-22-21(26-10-11-27-22)16-28-12-8-17(9-13-28)19(15-25)14-18-6-4-5-7-20(18)24;1-22(2,3)28-21-19(24-10-11-25-21)15-26-12-8-17(9-13-26)20(27)14-16-4-6-18(23)7-5-16;1-26-19-16(23-18(21)11-22-19)12-24-8-6-13(7-9-24)17(25)10-14-4-2-3-5-15(14)20;1-25-19-17(21-8-9-22-19)13-23-10-6-14(7-11-23)18(24)12-15-4-2-3-5-16(15)20;1-24-18-15(22-17(20)10-21-18)11-23-8-6-13(7-9-23)12-25-16-5-3-2-4-14(16)19/h4-12,15-16,22H,13-14,17-20H2,1-3H3;4-7,10-11,17,19H,8-9,12-14,16H2,1-3H3;4-7,10-11,17H,8-9,12-15H2,1-3H3;2-5,11,13H,6-10,12H2,1H3;2-5,8-9,14H,6-7,10-13H2,1H3;2-5,10,13H,6-9,11-12H2,1H3 |
| InChIKey | VPSIHHYTBKQKAD-UHFFFAOYSA-N |
| XLogP | 22.04 |
| TPSA | 330.80 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 166 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2279.76 |
| LogP ≤ 5 | 22.04 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 30 |